Stocks
Addex Therapeutics LtdADXN
NASDAQHealthcareBiotechnology$2.97
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company focused on developing oral small molecules that modulate G protein-coupled receptors, with a lead program in Parkinson's disease and additional candidates in epilepsy and other CNS disorders. Investors track ADXN for its allosteric modulation platform and potential partnerships with larger pharmaceutical firms.
52W Range: $2.56-$10.43
Congressional Interest in Addex Therapeutics Ltd (ADXN)
No congressional trades have been disclosed for Addex Therapeutics Ltd (ADXN) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading ADXN?
No congressional trades found for this stock.